320 related articles for article (PubMed ID: 21305617)
21. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
22. A drosophila model for EGFR-Ras and PI3K-dependent human glioma.
Read RD; Cavenee WK; Furnari FB; Thomas JB
PLoS Genet; 2009 Feb; 5(2):e1000374. PubMed ID: 19214224
[TBL] [Abstract][Full Text] [Related]
23. Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array.
Li J; Xue Y; Wenger A; Sun Y; Wang Z; Zhang C; Zhang Y; Fekete B; Rydenhag B; Jakola AS; Jiang T; Carén H; Fan X
Clin Cancer Res; 2019 Dec; 25(23):7068-7077. PubMed ID: 31481507
[TBL] [Abstract][Full Text] [Related]
24. Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases.
Zhang W; Lv Y; Xue Y; Wu C; Yao K; Zhang C; Jin Q; Huang R; Li J; Sun Y; Su X; Jiang T; Fan X
Oncotarget; 2016 Sep; 7(37):59098-59114. PubMed ID: 27385209
[TBL] [Abstract][Full Text] [Related]
25. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.
Daginakatte GC; Gutmann DH
Hum Mol Genet; 2007 May; 16(9):1098-112. PubMed ID: 17400655
[TBL] [Abstract][Full Text] [Related]
26. Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition.
Mondal G; Lee JC; Ravindranathan A; Villanueva-Meyer JE; Tran QT; Allen SJ; Barreto J; Gupta R; Doo P; Van Ziffle J; Onodera C; Devine P; Grenert JP; Samuel D; Li R; Metrock LK; Jin LW; Antony R; Alashari M; Cheshier S; Whipple NS; Bruggers C; Raffel C; Gupta N; Kline CN; Reddy A; Banerjee A; Hall MD; Mehta MP; Khatib Z; Maher OM; Brathwaite C; Pekmezci M; Phillips JJ; Bollen AW; Tihan T; Lucas JT; Broniscer A; Berger MS; Perry A; Orr BA; Solomon DA
Acta Neuropathol; 2020 Jun; 139(6):1071-1088. PubMed ID: 32303840
[TBL] [Abstract][Full Text] [Related]
27. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
Rahme GJ; Luikart BW; Cheng C; Israel MA
Neuro Oncol; 2018 Feb; 20(3):332-342. PubMed ID: 29016807
[TBL] [Abstract][Full Text] [Related]
28. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
29. Updated Insights on EGFR Signaling Pathways in Glioma.
Oprita A; Baloi SC; Staicu GA; Alexandru O; Tache DE; Danoiu S; Micu ES; Sevastre AS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435537
[TBL] [Abstract][Full Text] [Related]
30. Glioma models.
Dai C; Holland EC
Biochim Biophys Acta; 2001 Aug; 1551(1):M19-27. PubMed ID: 11553418
[TBL] [Abstract][Full Text] [Related]
31. Gliomagenesis: genetic alterations and mouse models.
Holland EC
Nat Rev Genet; 2001 Feb; 2(2):120-9. PubMed ID: 11253051
[TBL] [Abstract][Full Text] [Related]
32. Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.
Sievers P; Appay R; Schrimpf D; Stichel D; Reuss DE; Wefers AK; Reinhardt A; Coras R; Ruf VC; Schmid S; de Stricker K; Boldt HB; Kristensen BW; Petersen JK; Ulhøi BP; Gardberg M; Aronica E; Hasselblatt M; Brück W; Bielle F; Mokhtari K; Lhermitte B; Wick W; Herold-Mende C; Hänggi D; Brandner S; Giangaspero F; Capper D; Rushing E; Wesseling P; Pfister SM; Figarella-Branger D; von Deimling A; Sahm F; Jones DTW
Acta Neuropathol; 2019 Sep; 138(3):497-504. PubMed ID: 31250151
[TBL] [Abstract][Full Text] [Related]
33. Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.
Caskey LS; Fuller GN; Bruner JM; Yung WK; Sawaya RE; Holland EC; Zhang W
Histol Histopathol; 2000 Jul; 15(3):971-81. PubMed ID: 10963139
[TBL] [Abstract][Full Text] [Related]
34. Only in congenial soil: the microenvironment in brain tumorigenesis.
Rubin JB
Brain Pathol; 2009 Jan; 19(1):144-9. PubMed ID: 19076779
[TBL] [Abstract][Full Text] [Related]
35. A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells.
Misuraca KL; Hu G; Barton KL; Chung A; Becher OJ
Neoplasia; 2016 Jan; 18(1):60-70. PubMed ID: 26806352
[TBL] [Abstract][Full Text] [Related]
36. Modeling phenotypes of malignant gliomas.
Sampetrean O; Saya H
Cancer Sci; 2018 Jan; 109(1):6-14. PubMed ID: 28796931
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
38. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
[TBL] [Abstract][Full Text] [Related]
39. Molecular Classification of Diffuse Gliomas.
Kalidindi N; Or R; Babak S; Mason W
Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
[TBL] [Abstract][Full Text] [Related]
40. [Towards a molecular classification of gliomas].
Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]